Mast cell tryptase beta as a target in allergic inflammation: An evolving story

Sommerhoff CP, Schaschke N (2007)
CURRENT PHARMACEUTICAL DESIGN 13(3): 313-332.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
DOI
Autor*in
Sommerhoff, C. P.; Schaschke, NorbertUniBi
Einrichtung
Fakultät für Chemie > Organische Chemie III
Centrum für Biotechnologie > Arbeitsgruppe N. Schaschke
Centrum für Biotechnologie > Institut für Biochemie und Biotechnik
Stichworte
asthma; tryptase inhibitors; mast cells; tryptases; allergic inflammation
Erscheinungsjahr
2007
Zeitschriftentitel
CURRENT PHARMACEUTICAL DESIGN
Band
13
Ausgabe
3
Seite(n)
313-332
ISSN
1381-6128
Page URI
https://pub.uni-bielefeld.de/record/2403747

Zitieren

Sommerhoff CP, Schaschke N. Mast cell tryptase beta as a target in allergic inflammation: An evolving story. CURRENT PHARMACEUTICAL DESIGN. 2007;13(3):313-332.
Sommerhoff, C. P., & Schaschke, N. (2007). Mast cell tryptase beta as a target in allergic inflammation: An evolving story. CURRENT PHARMACEUTICAL DESIGN, 13(3), 313-332. https://doi.org/10.2174/138161207779313579
Sommerhoff, C. P., and Schaschke, Norbert. 2007. “Mast cell tryptase beta as a target in allergic inflammation: An evolving story”. CURRENT PHARMACEUTICAL DESIGN 13 (3): 313-332.
Sommerhoff, C. P., and Schaschke, N. (2007). Mast cell tryptase beta as a target in allergic inflammation: An evolving story. CURRENT PHARMACEUTICAL DESIGN 13, 313-332.
Sommerhoff, C.P., & Schaschke, N., 2007. Mast cell tryptase beta as a target in allergic inflammation: An evolving story. CURRENT PHARMACEUTICAL DESIGN, 13(3), p 313-332.
C.P. Sommerhoff and N. Schaschke, “Mast cell tryptase beta as a target in allergic inflammation: An evolving story”, CURRENT PHARMACEUTICAL DESIGN, vol. 13, 2007, pp. 313-332.
Sommerhoff, C.P., Schaschke, N.: Mast cell tryptase beta as a target in allergic inflammation: An evolving story. CURRENT PHARMACEUTICAL DESIGN. 13, 313-332 (2007).
Sommerhoff, C. P., and Schaschke, Norbert. “Mast cell tryptase beta as a target in allergic inflammation: An evolving story”. CURRENT PHARMACEUTICAL DESIGN 13.3 (2007): 313-332.

17 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Deciphering Biological Processes at the Tick-Host Interface Opens New Strategies for Treatment of Human Diseases.
Štibrániová I, Bartíková P, Holíková V, Kazimírová M., Front Physiol 10(), 2019
PMID: 31333488
Postmortem serum levels of IgE and mast cell tryptase in fatal asthma.
Scarpelli MP, Keller S, Tran L, Palmiere C., Forensic Sci Int 269(), 2016
PMID: 27888720
Rock, paper, scissors: harnessing complementarity in ortholog detection methods improves comparative genomic inference.
Maher MC, Hernandez RD., G3 (Bethesda) 5(4), 2015
PMID: 25711833
Characterization of gastric and neuronal histaminergic populations using a transgenic mouse model.
Walker AK, Park WM, Chuang JC, Perello M, Sakata I, Osborne-Lawrence S, Zigman JM., PLoS One 8(3), 2013
PMID: 23555941
Structure-based library design and the discovery of a potent and selective mast cell β-tryptase inhibitor as an oral therapeutic agent.
Liang G, Aldous S, Merriman G, Levell J, Pribish J, Cairns J, Chen X, Maignan S, Mathieu M, Tsay J, Sides K, Rebello S, Whitely B, Morize I, Pauls HW., Bioorg Med Chem Lett 22(2), 2012
PMID: 22192588
Dimerization of β-tryptase inhibitors, does it work for both basic and neutral P1 groups?
Liang G, Choi-Sledeski YM, Chen X, Gong Y, MacMillan EW, Tsay J, Sides K, Cairns J, Kulitzscher B, Aldous DJ, Morize I, Pauls HW., Bioorg Med Chem Lett 22(9), 2012
PMID: 22483389
Mast cell apoptosis induced by siramesine, a sigma-2 receptor agonist.
Spirkoski J, Melo FR, Grujic M, Calounova G, Lundequist A, Wernersson S, Pejler G., Biochem Pharmacol 84(12), 2012
PMID: 23058984
Protease inhibitors as models for the study of oxidative folding.
Arolas JL, Ventura S., Antioxid Redox Signal 14(1), 2011
PMID: 20812859
Engineered cystine knot miniproteins as potent inhibitors of human mast cell tryptase beta.
Sommerhoff CP, Avrutina O, Schmoldt HU, Gabrijelcic-Geiger D, Diederichsen U, Kolmar H., J Mol Biol 395(1), 2010
PMID: 19852971
Engineered cystine-knot miniproteins for diagnostic applications.
Kolmar H., Expert Rev Mol Diagn 10(3), 2010
PMID: 20370592
Extracellular proteases as targets for drug development.
Cudic M, Fields GB., Curr Protein Pept Sci 10(4), 2009
PMID: 19689354
Deciphering the structural basis that guides the oxidative folding of leech-derived tryptase inhibitor.
Pantoja-Uceda D, Arolas JL, Aviles FX, Santoro J, Ventura S, Sommerhoff CP., J Biol Chem 284(51), 2009
PMID: 19820233
Oxidative folding of leech-derived tryptase inhibitor via native disulfide-bonded intermediates.
Arolas JL, Bronsoms S, Aviles FX, Ventura S, Sommerhoff CP., Antioxid Redox Signal 10(1), 2008
PMID: 18004973
Head-to-tail cyclized cystine-knot peptides by a combined recombinant and chemical route of synthesis.
Avrutina O, Schmoldt HU, Gabrijelcic-Geiger D, Wentzel A, Frauendorf H, Sommerhoff CP, Diederichsen U, Kolmar H., Chembiochem 9(1), 2008
PMID: 18058774
Potent, nonpeptide inhibitors of human mast cell tryptase. Synthesis and biological evaluation of novel spirocyclic piperidine amide derivatives.
Costanzo MJ, Yabut SC, Zhang HC, White KB, de Garavilla L, Wang Y, Minor LK, Tounge BA, Barnakov AN, Lewandowski F, Milligan C, Spurlino JC, Abraham WM, Boswell-Smith V, Page CP, Maryanoff BE., Bioorg Med Chem Lett 18(6), 2008
PMID: 18272363
Alternative binding proteins: biological activity and therapeutic potential of cystine-knot miniproteins.
Kolmar H., FEBS J 275(11), 2008
PMID: 18435757
Enhanced protein expression in the baculovirus/insect cell system using engineered SUMO fusions.
Liu L, Spurrier J, Butt TR, Strickler JE., Protein Expr Purif 62(1), 2008
PMID: 18713650
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 17313363
PubMed | Europe PMC

Suchen in

Google Scholar